2,343 reports of this reaction
2.6% of all METHADONE reports
#8 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME is the #8 most commonly reported adverse reaction for METHADONE, manufactured by VistaPharm, LLC. There are 2,343 FDA adverse event reports linking METHADONE to DRUG WITHDRAWAL SYNDROME. This represents approximately 2.6% of all 88,944 adverse event reports for this drug.
Patients taking METHADONE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME is a less commonly reported adverse event for METHADONE, but still significant enough to appear in the safety profile.
In addition to drug withdrawal syndrome, the following adverse reactions have been reported for METHADONE:
The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 2,343 FDA reports for METHADONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME accounts for approximately 2.6% of all adverse event reports for METHADONE, making it a notable side effect.
If you experience drug withdrawal syndrome while taking METHADONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.